e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Experimental pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
NOX1 derived generation of reactive oxygen species in monocrotaline-induced pulmonary arterial hypertension of rats
F. Veit, M. Roth, B. Egemnazarov, H. A. Ghofrani, R. T. Schermuly, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Bad Nauheim, Germany)
Source:
Annual Congress 2010 - Experimental pulmonary hypertension
Session:
Experimental pulmonary hypertension
Session type:
Thematic Poster Session
Number:
1063
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Veit, M. Roth, B. Egemnazarov, H. A. Ghofrani, R. T. Schermuly, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Bad Nauheim, Germany). NOX1 derived generation of reactive oxygen species in monocrotaline-induced pulmonary arterial hypertension of rats. Eur Respir J 2010; 36: Suppl. 54, 1063
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Increased generation of reactive oxygen species in pulmonary arterial smooth muscle cells, isolated from monocrotaline-treated rats
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
Reactive oxygen species production by rat neutrophils in pulmonary arterial hypertension experimental model
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
MnTBAP reduces pulmonary vascular remodeling in experimental pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
The role of reactive oxygen species in pulmonary inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 531s
Year: 2003
TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
Two rat models of hemolysis-induced pulmonary hypertension
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats
Source: Eur Respir J 2009; 34: 731
Year: 2009
Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms
Source: Eur Respir J 2008; 32: 1639-1651
Year: 2008
The ROS controversy in hypoxic pulmonary hypertension revisited
Source: Eur Respir J, 51 (3) 1800276; 10.1183/13993003.00276-2018
Year: 2018
Acute effects of oxygen supplementation during exercise in patients with pulmonary arterial hypertension
Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases
Year: 2019
Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Early atorvastatin administration suppresses the oxygen-activating ability of rat neutrophils during monocrotalinin-induced pulmonary arterial hypertension (PAH).
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Pathways in pulmonary arterial hypertension: the future is here
Source: Eur Respir Rev 2012 21: 321-327
Year: 2012
Effects of oxygen supplementation during exercise on hemodynamic responses in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020
Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension
Source: Eur Respir J, 56 (5) 2000522; 10.1183/13993003.00522-2020
Year: 2020
The role of superoxide in hypoxic pulmonary vasoconstriction in chronically hypoxic rat lungs
Source: Eur Respir J 2004; 24: Suppl. 48, 95s
Year: 2004
Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 1483-1485
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept